SEC Form 4 · accession 0001209191-15-057871
AERIE PHARMACEUTICALS INC · AERI
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Michael du Toit
Director
Period of report
Jun 29, 2015
Accepted (ET)
Jul 1, 2015 · 3:08 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001337553
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1 | $17.18 | Jun 29, 2015 | A | 25,000 | A | — | Jun 29, 2025 | Common Stock | 25,000 | 25,000 | D |
Explanation of responses
- F1Subject to the reporting person's continued service on the board of directors of the issuer through the applicable vesting date, this option is scheduled to vest ratably over a three-year period on each of the first 12 quarterly anniversaries of June 29, 2015.